Marc A Silver

Summary

Affiliation: Advocate Christ Medical Center
Country: USA

Publications

  1. ncbi request reprint Current and emerging issues with B-type natriuretic peptide. Roundtable discussion
    Marc A Silver
    Department of Medicine and the Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    Congest Heart Fail 11:212-4. 2005
  2. ncbi request reprint BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases
    Marc A Silver
    Department of Medicine and Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL 60453 2600, USA
    Congest Heart Fail 10:1-30. 2004
  3. ncbi request reprint Systemic hypertension among women with uterine leiomyomata: potential final common pathways of target end-organ remodeling
    Marc A Silver
    Heart Failure Institute and the Department of Medicine, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    J Clin Hypertens (Greenwich) 7:664-8. 2005
  4. ncbi request reprint Evaluation of impedance cardiography as an alternative to pulmonary artery catheterization in critically ill patients
    Marc A Silver
    Department of Medicine and the Heart Failure Institute, Advocate Christ Hospital and Medical Center, Oak Lawn, IL 60453, USA
    Congest Heart Fail 10:17-21. 2004
  5. ncbi request reprint Acute and chronic oral magnesium supplementation: effects on endothelial function, exercise capacity, and quality of life in patients with symptomatic heart failure
    Johanna C Fuentes
    Department of Medicine and Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    Congest Heart Fail 12:9-13. 2006
  6. ncbi request reprint Mechanisms and evidence for the role of enhanced external counterpulsation in heart failure management
    Marc A Silver
    Advocate Christ Medical Center, Suite 319 South, Oak Lawn, IL 60453, USA
    Curr Heart Fail Rep 3:25-32. 2006
  7. ncbi request reprint Statin cardiomyopathy? A potential role for Co-Enzyme Q10 therapy for statin-induced changes in diastolic LV performance: description of a clinical protocol
    Marc A Silver
    Heart Failure Institute, Division of Cardiology, Department of Medicine, Advocate Christ Medical Center and the University of Illinois Christ Cardiovascular Disease Fellowship Program, Oak Lawn, IL 60453, USA
    Biofactors 18:125-7. 2003
  8. ncbi request reprint The natriuretic peptide system: kidney and cardiovascular effects
    Marc A Silver
    Advocate Christ Medical Center, 4440 West 95th Street, Oak Lawn, IL 60453, USA
    Curr Opin Nephrol Hypertens 15:14-21. 2006
  9. ncbi request reprint High incidence of elevated B-type natriuretic peptide levels and risk factors for heart failure in an unselected at-risk population (stage A): implications for heart failure screening programs
    Marc A Silver
    Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    Congest Heart Fail 9:127-32. 2003
  10. ncbi request reprint Heart failure advances... going to the dogs
    Marc A Silver
    Department of Medicine and the Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    Congest Heart Fail 11:215. 2005

Detail Information

Publications51

  1. ncbi request reprint Current and emerging issues with B-type natriuretic peptide. Roundtable discussion
    Marc A Silver
    Department of Medicine and the Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    Congest Heart Fail 11:212-4. 2005
    ..The panel gathered to review some of the questions that emerged from the symposium and the questions raised by the attendees. These are of interest and importance to all interested in heart failure and B-type natriuretic peptide...
  2. ncbi request reprint BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases
    Marc A Silver
    Department of Medicine and Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL 60453 2600, USA
    Congest Heart Fail 10:1-30. 2004
    ..An expert Consensus Panel with basic, methodological, and clinical expertise was convened to summarize current knowledge in these areas and the findings and consensus statements are contained herein...
  3. ncbi request reprint Systemic hypertension among women with uterine leiomyomata: potential final common pathways of target end-organ remodeling
    Marc A Silver
    Heart Failure Institute and the Department of Medicine, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    J Clin Hypertens (Greenwich) 7:664-8. 2005
    ..Thus there appears to be an association between leiomyomata and hypertension, which needs to be explored in future prospective trials...
  4. ncbi request reprint Evaluation of impedance cardiography as an alternative to pulmonary artery catheterization in critically ill patients
    Marc A Silver
    Department of Medicine and the Heart Failure Institute, Advocate Christ Hospital and Medical Center, Oak Lawn, IL 60453, USA
    Congest Heart Fail 10:17-21. 2004
    ..2%-87.8%). ICG can replace the pulmonary artery catheter in coronary care unit patients, and clinicians utilizing ICG believe it aids medical decision making and improves patient outcomes...
  5. ncbi request reprint Acute and chronic oral magnesium supplementation: effects on endothelial function, exercise capacity, and quality of life in patients with symptomatic heart failure
    Johanna C Fuentes
    Department of Medicine and Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    Congest Heart Fail 12:9-13. 2006
    ..This study suggests that chronic supplementation with oral magnesium is well tolerated and could improve endothelial function in symptomatic heart failure patients...
  6. ncbi request reprint Mechanisms and evidence for the role of enhanced external counterpulsation in heart failure management
    Marc A Silver
    Advocate Christ Medical Center, Suite 319 South, Oak Lawn, IL 60453, USA
    Curr Heart Fail Rep 3:25-32. 2006
    ..This paper summarizes some of the mechanisms and outcomes of EECP in HF patients and helps to elucidate the role of EECP in the management of patients with chronic HF...
  7. ncbi request reprint Statin cardiomyopathy? A potential role for Co-Enzyme Q10 therapy for statin-induced changes in diastolic LV performance: description of a clinical protocol
    Marc A Silver
    Heart Failure Institute, Division of Cardiology, Department of Medicine, Advocate Christ Medical Center and the University of Illinois Christ Cardiovascular Disease Fellowship Program, Oak Lawn, IL 60453, USA
    Biofactors 18:125-7. 2003
    ..Since myocardial diastolic function is a highly ATP dependent, we reasoned that early changes of diastolic function may be an early marker of ventricular dysfunction...
  8. ncbi request reprint The natriuretic peptide system: kidney and cardiovascular effects
    Marc A Silver
    Advocate Christ Medical Center, 4440 West 95th Street, Oak Lawn, IL 60453, USA
    Curr Opin Nephrol Hypertens 15:14-21. 2006
    ..In addition, synthetic NPs such as nesiritide are available for use in management of patients with acutely decompensated congestive HF...
  9. ncbi request reprint High incidence of elevated B-type natriuretic peptide levels and risk factors for heart failure in an unselected at-risk population (stage A): implications for heart failure screening programs
    Marc A Silver
    Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    Congest Heart Fail 9:127-32. 2003
    ..Increased public and physician awareness and information are needed to transform screening opportunities into a strategic approach to improve health care and HF prevention...
  10. ncbi request reprint Heart failure advances... going to the dogs
    Marc A Silver
    Department of Medicine and the Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    Congest Heart Fail 11:215. 2005
  11. doi request reprint Depression and heart failure: an overview of what we know and don't know
    Marc A Silver
    Clinical Professor of Medicine, University of Illinois, Chicago, IL, USA
    Cleve Clin J Med 77:S7-S11. 2010
    ..Nevertheless, early identification of depression in heart failure patients is imperative, as it can facilitate intervention attempts...
  12. ncbi request reprint Optimizing treatment and outcomes in acute heart failure: beyond initial triage
    Marc A Silver
    Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    Congest Heart Fail 12:137-45. 2006
    ....
  13. ncbi request reprint Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure
    Marc A Silver
    Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA
    J Am Coll Cardiol 39:798-803. 2002
    ....
  14. ncbi request reprint Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction
    Marc A Silver
    Heart Failure Institute, Department of Medicine, Advocate Christ Medical Center, University of Illinois Christ Cardiovascular Disease Fellowship Program, Oak Lawn, Illinois 60453, USA
    Am J Cardiol 94:1306-10. 2004
    ..Statin therapy worsened diastolic parameters in most patients; coenzyme Q(10) supplementation in patients with worsening diastolic function with statin therapy improved parameters of diastolic function...
  15. pmc Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device
    Mark S Slaughter
    Cardiac Surgery Research and Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA
    Tex Heart Inst J 35:245-9. 2008
    ..They also suggest that modifications made to the HeartMate LVAD since the REMATCH trial have resulted in fewer complications, and that better patient selection and supportive care have improved outcomes...
  16. doi request reprint Self-management counseling in patients with heart failure: the heart failure adherence and retention randomized behavioral trial
    Lynda H Powell
    Department of Preventive Medicine, Rush University Medical Center, 1700 W Van Buren St, Chicago, IL 60612, USA
    JAMA 304:1331-8. 2010
    ..Motivating patients with heart failure to adhere to medical advice has not translated into clinical benefit, but past trials have had methodological limitations...
  17. ncbi request reprint Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure
    Arthur M Feldman
    Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania, USA
    J Am Coll Cardiol 48:1198-205. 2006
    ....
  18. doi request reprint Improvement in early oxygen uptake kinetics with left ventricular assist device support
    Chad M Feldman
    Internal Medicine, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    ASAIO J 54:406-11. 2008
    ..7 seconds to 35.8 +/- 13.3 seconds (p = 0.046) with LVAD support. Improved oxygen kinetics suggests improved peripheral utilization of oxygen, and may offer an additional clinical parameter to predict the likelihood of sustained recovery...
  19. doi request reprint Destination therapy: safety and feasibility of national and international travel
    Laura A Coyle
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    ASAIO J 54:172-6. 2008
    ..All patients returned home safely for routine follow-up. Long-distance travel is possible for DT patients. Anticipating potential problems and careful planning is necessary for safe national and international travel...
  20. ncbi request reprint Treating heart failure with enhanced external counterpulsation (EECP): design of the Prospective Evaluation of EECP in Heart Failure (PEECH) trial
    Arthur M Feldman
    Department of Medicine, Jefferson Medical College, 1025 Walnut Street, Philadelphia, PA 19607, USA
    J Card Fail 11:240-5. 2005
    ..Thus a larger, controlled study of EECP in patients with stable HF (New York Heart Association [NYHA] classes II and III) and LVD was undertaken...
  21. ncbi request reprint Enhanced external counterpulsation: bringing the concept of the intraaortic balloon pump to the outpatient setting
    Helen Lonergan-Thomas
    Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA
    Dimens Crit Care Nurs 23:119-21. 2004
    ..Enhanced external counterpulsation can now be used in patients with congestive heart failure. As our population ages, we will see more patients with this challenging diagnosis. The authors discuss this exciting treatment...
  22. ncbi request reprint Utilization of acoustic signatures to identify HeartMate XVE device end-of-life
    Mark S Slaughter
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA
    J Heart Lung Transplant 26:579-83. 2007
    ..In this study we assess a non-invasive technique using acoustic signals generated from the HeartMate XVE LVAD to potentially identify impending device end-of-life issues...
  23. ncbi request reprint Home discharge experience with the Thoratec TLC-II portable driver
    Mark S Slaughter
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    ASAIO J 53:132-5. 2007
    ..There were no readmissions for device malfunction, emergency battery utilization or back-up unit use. These results demonstrate that the Thoratec TLC-II portable driver is safe, reliable, and can be effectively managed at home...
  24. ncbi request reprint Optimizing treatment of chronic decompensated heart failure in the outpatient setting
    Marc A Silver
    Department of Medicine, Heart Failure Institute, Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    Rev Cardiovasc Med 5:S28-36. 2004
    ..In other patients, nonpharmacologic approaches used in combination with drug therapy may help improve functional status and reduce mortality...
  25. ncbi request reprint Efficacy of nonsteroidal anti-inflammatory medications for prevention of atrial fibrillation following coronary artery bypass graft surgery
    Kiran K Cheruku
    Advocate Christ Medical Center, Oak Lawn, IL 60453 2600, USA
    Prev Cardiol 7:13-8. 2004
    ..8%) in the ibuprofen group (p<0.017). Nonsteroidal anti-inflammatory medications were relatively safe and effective in significantly reducing the incidence of atrial fibrillation after coronary artery bypass graft surgery...
  26. ncbi request reprint Left ventricular assist device weaning: hemodynamic response and relationship to stroke volume and rate reduction protocols
    Mark S Slaughter
    Mechanical Assist Device Program, Advocate Christ Medical Center, Oak Lawn, IL 60453, USA
    ASAIO J 52:228-33. 2006
    ..The long-term effects of steady-state and transient LV mechanical reloading on myocardial structure and function toward achieving sustained myocardial recovery warrant further investigation...
  27. ncbi request reprint Impact of body mass index on outcomes of enhanced external counterpulsation therapy
    Peter A McCullough
    Division of Cardiology, Department of Medicine, Nutrition and Preventive Medicine, William Beaumont Hospital, Royal Oak, MI 48073, USA
    Am Heart J 151:139. 2006
    ..We evaluated the association of baseline body mass index (BMI) on the outcomes of enhanced external counterpulsation (EECP) therapy for chronic stable angina...
  28. ncbi request reprint Management of aortic insufficiency with continuous flow left ventricular assist devices: bioprosthetic valve replacement
    Chad M Feldman
    Advocate Christ Medical Center, Mechanical Assist Device Program, Oak Lawn, Illinois 60453, USA
    J Heart Lung Transplant 25:1410-2. 2006
    ..We report on two patients with bioprosthetic aortic valve replacement for aortic insufficiency at the time of HeartMate II LVAD insertion...
  29. ncbi request reprint Increasing self-management skills in heart failure patients: a pilot study
    Kristin J Flynn
    Department of Preventive Medicine, Rush University Medical Center, Chicago, IL 60612, USA
    Congest Heart Fail 11:297-302. 2005
    ..001) and in several psychosocial outcomes. The success of this pilot study suggests the need for a randomized clinical trial to test the efficacy of group-based self-management training on medical outcomes...
  30. ncbi request reprint Current and potential applications of left ventricular assist devices
    Pamela Cianci
    Advocate Christ Medical Center, Oak Lawn, Illinois, USA
    J Cardiovasc Nurs 18:17-22. 2003
    ..As VAD science advances, nurses will needs to understand its practice implications...
  31. ncbi request reprint Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial
    Michael S Cuffe
    Northwestern University Medical School, Division of Cardiology, 201 E Huron St, Galter 10 240, Chicago, IL 60611, USA
    JAMA 287:1541-7. 2002
    ..Although intravenous inotropic therapy usually produces beneficial hemodynamic effects and is labeled for use in the care of such patients, the effect of such therapy on intermediate-term clinical outcomes is uncertain...
  32. doi request reprint Management of anemia in heart failure
    Thomas D Stamos
    Department of Medicine, Section of Cardiology, University of Illinois at Chicago, Chicago, Illinois, USA
    Curr Opin Cardiol 25:148-54. 2010
    ..Anemia would appear to be a reasonable treatment target for patients with heart failure. The review will discuss the potential causes of anemia in heart failure patients and give an up-to-date overview of treatment trials...
  33. doi request reprint Post-acute care: the role of natriuretic peptides
    Alan Maisel
    San Diego VA Medical Hospital and University of California San Diego, CA 92161, USA
    Congest Heart Fail 18:S14-6. 2012
    ....
  34. ncbi request reprint Symptomatic calcific constrictive pericarditis presenting years after presumed resolved inflammatory heart disease
    Tanyanan Tanawuttiwat
    Heart Failure Institute, Department of Medicine, Advocate Christ Medical Center University of Illinois at Chicago, USA
    Am Heart Hosp J 8:E130-2. 2010
    ..In conclusion, close monitoring and careful evaluation of patients with presumed inflammatory heart disease is warranted because of the potential for late-occurring chronic constrictive sequelae...
  35. ncbi request reprint Heat therapy in the management of heart failure
    Adrianna A Weber
    Department of Medicine, Heart Failure Institute, University of Illinois at Chicago, Oak Lawn, IL 60453, USA
    Congest Heart Fail 13:81-3. 2007
    ..Hopefully future studies will continue to explore heat therapy as adjunctive care for heart failure patients...
  36. ncbi request reprint Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatment
    Carl V Leier
    Division of Cardiology, Heart Lung Research Institute, The Ohio State University Medical Center, Columbus, OH 43210, USA
    Congest Heart Fail 8:98-124. 2002
  37. ncbi request reprint Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure
    Milton Packer
    University of Texas Southwestern Medical Center, Dallas, Texas 75390 8822, USA
    J Am Coll Cardiol 47:2245-52. 2006
    ..This study sought to assess the potential utility of impedance cardiography (ICG) in predicting clinical deterioration in ambulatory patients with heart failure (HF)...
  38. ncbi request reprint Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial)
    Clyde W Yancy
    University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Am J Cardiol 94:595-601. 2004
    ..Additional studies are needed to determine the effect of outpatient serial infusions of nesiritide on rates of morbidity and mortality in advanced heart failure...
  39. ncbi request reprint Beyond the four quadrants: the critical and emerging role of impedance cardiography in heart failure
    John E Strobeck
    Congest Heart Fail 10:1-6. 2004
  40. ncbi request reprint Nesiritide in acute heart failure
    Andrew J Burger
    Lancet 362:998; author reply 998-9. 2003
  41. ncbi request reprint Decompensated heart failure: is there a role for the outpatient use of nesiritide?
    Clyde W Yancy
    University of Texas Southwestern Medical Center, Department of Internal Medicine Cardiology Division, CS7 102, 5323 Harry Hines Boulevard, Dallas, TX 75235, USA
    Congest Heart Fail 10:230-6. 2004
    ..Such an approach, once validated, should be integrated into an evidence-based HF disease management program...
  42. ncbi request reprint New approaches to hemodynamic measurement cool devices but a shaky infrastructure
    Marc A Silver
    J Am Coll Cardiol 50:2383-4. 2007
  43. ncbi request reprint Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection
    Katherine Lietz
    Cardiovascular Division, University of Minnesota, Minneapolis, USA
    Circulation 116:497-505. 2007
    ..In the present study, we describe outcomes of DT in the post-REMATCH era in the United States...
  44. ncbi request reprint Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure
    W Franklin Peacock
    Department of Emergency Medicine, The Cleveland Clinic Foundation, OH 44195, USA
    Am J Emerg Med 23:327-31. 2005
    ..03]). Both treatment groups had similar incidences of symptomatic and asymptomatic hypotension. These data demonstrate that early administration of nesiritide in the emergency department is a safe and effective treatment of heart failure...
  45. ncbi request reprint The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design
    Clyde W Yancy
    Baylor University Medical Center, Heart and Vascular Institute, Dallas, TX 75246, USA
    Am Heart J 153:478-84. 2007
    ..Within a prespecified subset of high-risk patients, a potential signal of benefit on a combined end point of mortality and cardiovascular hospitalization was identified...
  46. ncbi request reprint Enhanced external counterpulsation improves exercise duration and peak oxygen consumption in older patients with heart failure: a subgroup analysis of the PEECH trial
    Charles W Abbottsmith
    The Ohio Heart and Vascular Center, Cincinnati, OH 45219, USA
    Congest Heart Fail 12:307-11. 2006
    ..017). The authors conclude that an older subgroup of PEECH subjects confirms the beneficial effect of EECP in patients with chronic, stable, mild-to-moderate heart failure...
  47. ncbi request reprint Angina patients with diastolic versus systolic heart failure demonstrate comparable immediate and one-year benefit from enhanced external counterpulsation
    William E Lawson
    SUNY Stony Brook, Stony Brook, NY 11740, USA
    J Card Fail 11:61-6. 2005
    ..Whether EECP produces similar immediate and sustained benefits and freedom from adverse events (MACE) at 1 year in patients with severe systolic dysfunction versus diastolic dysfunction is unknown...
  48. ncbi request reprint Using homeostatic peptides in decompensated heart failure a reasonable paradigm but a flawed practice?
    Marc A Silver
    J Am Coll Cardiol 50:1841-3. 2007
  49. ncbi request reprint ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary
    Sharon A Hunt
    American College of Cardiology American Heart Association Task Force on Practice Guidelines
    J Heart Lung Transplant 21:189-203. 2002
  50. ncbi request reprint Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy
    CHRISTOPHER M O'CONNOR
    Duke University Medical Center, Durham, North Carolina, USA
    Am J Cardiol 95:558-64. 2005
    ..Beta-blocker therapy with bucindolol appears to attenuate the risk of nonfatal MI in this population...
  51. ncbi request reprint Thermal therapy: a viable adjunct in the treatment of heart failure?
    Tofy Mussivand
    University of Ottawa Heart Institute, Ottawa, Ontario, Canada
    Congest Heart Fail 14:180-6. 2008
    ..The clinical evidence highlights repeatable and compelling data showing that thermal therapy may provide an important and viable adjunct in the treatment of heart failure...